Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 47 citing Suleiman: Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients.... (0.08 sec) 

Neovascularization in human atherosclerosis

- ahajournals.org
PR Moreno, K Purushothaman… - Circulation, 2006 - Am Heart Assoc
Figure 1. A, Volume-rendered high-resolution, 3-dimensional micro-CT image of the descending
aorta vasa vasorum. B and C, Corresponding histological cross sections demonstrate atherosclerotic
lesions in the inferior vena cava (black arrow). D, Highlighted differentiated arterial (red) ...
Cited by 112 - Related articles - BL Direct - All 9 versions

[PDF] Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage …


AP Levy, JE Levy, S Kalet-Litman, R Miller- … - … and Vascular Biology, 2007 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Haptoglobin Genotype Is a Determinant of Iron, Lipid
Cited by 40 - Related articles - All 9 versions

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle- …

- ahajournals.org
U Milman, S Blum, C Shapira, D Aronson, R … - … , and Vascular Biology, 2008 - Am Heart Assoc
Objective— Clinical trials of vitamin E have failed to demonstrate a decrease in cardiovascular
events. However, these studies did not address possible benefit to subgroups with increased
oxidative stress. Haptoglobin (Hp), a major antioxidant protein, is a determinant of ...
Cited by 35 - Related articles - All 5 versions

Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by …


J Guetta, M Strauss, NS Levy, L Fahoum, AP Levy - Atherosclerosis, 2007 - Elsevier
The haptoglobin genotype has been demonstrated to be an independent risk factor for CVD
in multiple epidemiological studies. The primary function of haptoglobin is to mitigate the deleterious
effects of extracorpuscular hemoglobin. We sought to determine if the protein products of ...
Cited by 33 - Related articles - All 18 versions

Downregulation of the hemoglobin scavenger receptor in individuals with diabetes …

- ahajournals.org
AP Levy, K Purushothaman, NS Levy, M … - Circulation …, 2007 - Am Heart Assoc
In individuals with diabetes mellitus (DM), the haptoglobin (Hp) genotype is a major determinant
of susceptibility to myocardial infarction. We have proposed that this is because of DM and Hp
genotype–dependent differences in the response to intraplaque hemorrhage. The ...
Cited by 31 - Related articles - All 8 versions

Haptoglobin genotype determines myocardial infarct size in diabetic mice

- onlinejacc.org
S Blum, R Asaf, J Guetta, R Miller-Lotan, R Asleh, R … - Journal of the American …, 2007 - Elsevier
Cited by 19 - Related articles - BL Direct - All 16 versions

[PDF] Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in …


RMLR Asleh, MHT Aviram, MLJE Yulish, BBS … - Circulation …, 2006 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Haptoglobin Genotype Is a Regulator of Reverse Cholesterol
Cited by 18 - Related articles - All 8 versions

Application of pharmacogenomics in the prevention of diabetic cardiovascular …


AP Levy - Pharmacology and Therapeutics, 2006 - Elsevier
Atherosclerotic cardiovascular disease (CVD) and diabetic vascular disease have been associated
with an increase in oxidative stress. Mechanistic studies in vitro and in animals have demonstrated
a direct role for oxidatively modified protein and lipid molecules in the pathophysiology of ...
Cited by 16 - Related articles - All 6 versions

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 …

- diabetesjournals.org
R Asleh, S Blum, S Kalet-Litman, J Alshiek, R Miller- … - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—Pharmacogenomics is a key component of personalized medicine. The Israel
Cardiovascular Events Reduction with Vitamin E Study, a prospective placebo-controlled
study, recently demonstrated that vitamin E could dramatically reduce CVD in individuals ...
Cited by 15 - Related articles - All 4 versions

Update on advances in atherothrombosis


J Sanz, PR Moreno, V Fuster - Nature Clinical Practice Cardiovascular …, 2007 - nature.com
J Sanz completed his Medicine and Cardiology training in Madrid, Spain. He joined Mount Sinai
School of Medicine, New York, NY, USA, in 2002 as a Research Fellow in the Cardiac MR/CT
Program. His research interests include noninvasive cardiovascular imaging, with a ...
Cited by 11 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google